OraSure Technologies | OSUR - Interest Expense On Debt


OraSure Technologies reported 2.91M in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
Agilent USD 27M 1000K Sep/2025
AngioDynamics USD 100K 134K Feb/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Bio Techne USD 2.18M 173K Jun/2025
Bio-Rad Laboratories USD 12.3M 100K Sep/2025
Bruker USD 20M 4.3M Sep/2025
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 25.4M 4.56M Sep/2025
Danaher USD 55M 12M Dec/2025
Dentsply International USD 23M 1000K Sep/2025
Dexcom USD 4.7M 0 Sep/2025
Exact Sciences USD 9.79M 46K Sep/2025
Hologic USD 27.6M 1000K Dec/2025
Illumina USD 25M 0 Sep/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 800K 100K Mar/2025
OraSure Technologies 2.91M 130K Dec/2024
Quidel USD 5.68B 5.63B Sep/2025
Repligen USD 5.41M 60K Sep/2025
Revvity USD 23.51M 742K Dec/2025
STAAR Surgical USD 1000 0 Dec/2024
Thermo Fisher Scientific USD 365M 18M Dec/2025
Trinity Biotech USD 3.33M 50K Sep/2025
Waters USD 8.62M 18.02M Dec/2025